For women who want added breast volume but don't want the scarring and foreign implants used in traditional breast augmentation a preferred alternative is natural breast augmentation. These procedures use the patient's own fat which is transferred into the breast after removal via liposuction. Some question the safety of these procedures however as there is little known about the long term effects of fat transfer to the breast.
A new study published in the January issue of the American Society of Aesthetic Plastic Surgery's (ASAPS) Aesthetic Surgery Journal examines disparities in the data between clinical and certain laboratory based scientific literature regarding natural breast augmentation. The authors have found in looking at published clinical experience with over 2,000 patients that there is no increased risk of development, metastasis or recurrence of breast cancer with fat transfer to the breast.
In the article, the authors explore the issues and find that the discrepancies in data between the lab and the clinic can be explained by the artificial conditions often used in lab studies.
Christopher Calhoun, CEO of Cytori Therapeutics, manufacturer of the fat processing systems Celution and PureGraft, said in a press release, "There is increased patient and physician demand for our technologies and this careful review supports our view that our recommended fat grafting techniques are safe in the breast. We will continue to conduct our own safety research and analyze data from sources external to Cytori, as part of the regulatory progress and the ultimate commercial adoption of our products."